SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001808805-23-000016
Filing Date
2023-03-01
Accepted
2023-03-01 15:30:45
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A nautilus-schedule13daxsuja.htm SC 13D/A 42735
  Complete submission text file 0001808805-23-000016.txt   44486
Mailing Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102 206-333-2001
Nautilus Biotechnology, Inc. (Filed by) CIK: 0001808805 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 3826 Laboratory Analytical Instruments

Mailing Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102 206-333-2001
Nautilus Biotechnology, Inc. (Subject) CIK: 0001808805 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91615 | Film No.: 23693008
SIC: 3826 Laboratory Analytical Instruments